Enhanced NF-κB Signaling in Type-2 Dendritic Cells at Baseline Predicts Non-Response to Adalimumab in Psoriasis

Lesional skin of non-responders contains higher numbers of dermal dendritic cells expressing the maturation marker CD83 and producing IL-23, and increased numbers of IL-17⁺ T cells.